Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
Travere plans a webcast presentation at Stifel’s 2026 virtual immunology and inflammation forum, with a replay available for 30 days.
Live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations. Replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260917000487/en/
Investors:
888-969-7879
ir@travere.com
Media:
888-969-7879
mediarelations@travere.com
Source: Travere Therapeutics, Inc.